IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

PURPOSE: To report toxicity and early survival data for IDEAL-CRT, a trial of dose-escalated concurrent chemoradiotherapy (CRT) for non-small cell lung cancer. PATIENTS AND METHODS: Patients received tumor doses of 63 to 73 Gy in 30 once-daily fractions over 6 weeks with 2 concurrent cycles of cispl...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Radiat Oncol Biol Phys
Main Authors: Landau, David B., Hughes, Laura, Baker, Angela, Bates, Andrew T., Bayne, Michael C., Counsell, Nicholas, Garcia-Alonso, Angel, Harden, Susan V., Hicks, Jonathan D., Hughes, Simon R., Illsley, Marianne C., Khan, Iftekhar, Laurence, Virginia, Malik, Zafar, Mayles, Helen, Mayles, William Philip M., Miles, Elizabeth, Mohammed, Nazia, Ngai, Yenting, Parsons, Emma, Spicer, James, Wells, Paula, Wilkinson, Dean, Fenwick, John D.
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Science Inc 2016
נושאים:
Clinical Investigation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4959796/
https://ncbi.nlm.nih.gov/pubmed/27296040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.03.031
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים